Chemicals and Drugs

Antifibrotic Agents

These agents are used to reduce FIBROSIS affecting organs and formation of scar TISSUES such as in SCLERODERMA patients.

National Library of MedicineMedical Subject Headings2026

Structured Summary

Abstract

These agents are used to reduce FIBROSIS affecting organs and formation of scar TISSUES such as in SCLERODERMA patients.

MeSH Record

Classification

Broader headings

Related Concepts

Knowledge Graph

Loading graph…

Drag nodes to rearrange; hover to trace links; click a node to open its page.

MeSH Record

Synonyms

2 entry terms
  • Anti-Fibrotic Agents
  • Agents, Anti-Fibrotic

MeSH Record

Aspects Covered

22 allowable subheadings

Indexed with the subheadings administration & dosage, adverse effects, analysis, blood, cerebrospinal fluid, chemical synthesis, chemistry, classification, economics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, poisoning, radiation effects, standards, supply & distribution, therapeutic use, toxicity, urine.

MeSH Record

History Note

2022

MeSH Hierarchy

Tree Number

  1. D27.505.954.158w.273

AMA Style

References

  1. National Library of Medicine. Antifibrotic Agents. Medical Subject Headings (MeSH). 2026. Unique ID D000088962. http://id.nlm.nih.gov/mesh/2026/D000088962
  2. Antifibrotic Agents. In: Wikidata. https://www.wikidata.org/wiki/Q112073596